INS and type 2 diabetes mellitus: Interestingly, this often leads to reduced serum glucose levels (attributed to the enhanced hepatic uptake), and while it may be beneficial by lowering T2DM risk, can alter insulin signaling and further contribute to the progression of MAFLD (16, 23).